PT3120852T - Agente preventivo e/ou terapêutico para doenças imunitárias - Google Patents

Agente preventivo e/ou terapêutico para doenças imunitárias

Info

Publication number
PT3120852T
PT3120852T PT16743556T PT16743556T PT3120852T PT 3120852 T PT3120852 T PT 3120852T PT 16743556 T PT16743556 T PT 16743556T PT 16743556 T PT16743556 T PT 16743556T PT 3120852 T PT3120852 T PT 3120852T
Authority
PT
Portugal
Prior art keywords
preventive
therapeutic agent
immune diseases
immune
diseases
Prior art date
Application number
PT16743556T
Other languages
English (en)
Inventor
Hosoi Fumihito
Nakachi Yoshinori
KAJIWARA Daisuke
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of PT3120852T publication Critical patent/PT3120852T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
PT16743556T 2015-01-30 2016-01-29 Agente preventivo e/ou terapêutico para doenças imunitárias PT3120852T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2015017386 2015-01-30

Publications (1)

Publication Number Publication Date
PT3120852T true PT3120852T (pt) 2019-07-16

Family

ID=56543555

Family Applications (1)

Application Number Title Priority Date Filing Date
PT16743556T PT3120852T (pt) 2015-01-30 2016-01-29 Agente preventivo e/ou terapêutico para doenças imunitárias

Country Status (21)

Country Link
US (1) US9782412B2 (pt)
EP (1) EP3120852B1 (pt)
JP (1) JP6093485B2 (pt)
KR (1) KR101858421B1 (pt)
CN (2) CN107206001B (pt)
AU (1) AU2016213030B2 (pt)
BR (1) BR112017016278B1 (pt)
CA (1) CA2975372C (pt)
DK (1) DK3120852T3 (pt)
ES (1) ES2734364T3 (pt)
HU (1) HUE045532T2 (pt)
MX (1) MX2017009863A (pt)
MY (1) MY197518A (pt)
PH (1) PH12017501336A1 (pt)
PL (1) PL3120852T3 (pt)
PT (1) PT3120852T (pt)
RU (1) RU2705154C2 (pt)
SG (1) SG11201704430SA (pt)
TR (1) TR201910158T4 (pt)
TW (1) TWI638817B (pt)
WO (1) WO2016121953A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112017016318B1 (pt) 2015-01-30 2023-09-26 Taiho Pharmaceutical Co., Ltd Sal de ácido fumárico, inibidor de btk, composição farmacêutica e agente antitumoral compreendendo o dito sal e uso do dito sal
US20230064254A1 (en) * 2019-12-19 2023-03-02 Taiho Pharmaceutical Co., Ltd. Therapeutic agent containing fused pyrimidine compound as active ingredient
CN112209894B (zh) * 2020-10-23 2023-06-06 贵州医科大学 5-芳基取代2-氨基苯并恶唑类衍生物、制备方法及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2631664C (en) * 2005-12-08 2012-05-08 Abbott Laboratories 9-membered heterobicyclic compounds as inhibitors of protein kinases
RS51965B (en) * 2006-09-13 2012-02-29 Takeda Pharmaceutical Company Limited USE 2-6- (3-AMINO-PIPERIDIN-1-IL) -3-METHYL-2,4-DIOXO-3,4-DIHYDRO-2H-PYRIMIDIN-1-ILMETHYL-4-FLUORO-BENZONITRIL FOR THE TREATMENT OF DIABETES, Cancers, autoimmune disorders and HIV infections
ES2403546T3 (es) * 2006-11-03 2013-05-20 Pharmacyclics, Inc. Sonda de actividad de la tirosina-cinasa de Bruton y procedimiento de utilización
WO2009057733A1 (ja) * 2007-10-31 2009-05-07 Santen Pharmaceutical Co., Ltd. 血管新生阻害活性を有する新規インドール誘導体
JP2011526299A (ja) 2008-06-27 2011-10-06 アビラ セラピューティクス, インコーポレイテッド ヘテロアリール化合物およびそれらの使用
US8338439B2 (en) 2008-06-27 2012-12-25 Celgene Avilomics Research, Inc. 2,4-disubstituted pyrimidines useful as kinase inhibitors
KR20140048968A (ko) * 2011-07-13 2014-04-24 파마시클릭스, 인코포레이티드 브루톤형 티로신 키나제의 억제제
PT2657233E (pt) 2012-01-19 2014-10-24 Taiho Pharmaceutical Co Ltd Composto de alcinil-benzeno substituído nas posições 3 e 5 e um seu sal
EP2890691B1 (en) * 2012-08-31 2018-04-25 Principia Biopharma Inc. Benzimidazole derivatives as itk inhibitors
CN105452257B (zh) 2013-08-12 2017-09-05 大鹏药品工业株式会社 新型稠合嘧啶化合物或其盐

Also Published As

Publication number Publication date
US9782412B2 (en) 2017-10-10
ES2734364T3 (es) 2019-12-05
US20170042900A1 (en) 2017-02-16
EP3120852A1 (en) 2017-01-25
CA2975372A1 (en) 2016-08-04
MX2017009863A (es) 2017-11-15
KR20170083640A (ko) 2017-07-18
HUE045532T2 (hu) 2020-01-28
TR201910158T4 (tr) 2019-07-22
KR101858421B1 (ko) 2018-05-15
DK3120852T3 (da) 2019-07-29
PH12017501336A1 (en) 2017-12-11
EP3120852B1 (en) 2019-05-01
AU2016213030B2 (en) 2019-01-31
CN107206001B (zh) 2021-09-28
MY197518A (en) 2023-06-19
EP3120852A4 (en) 2017-05-24
SG11201704430SA (en) 2017-08-30
RU2017127126A (ru) 2019-03-01
BR112017016278A2 (pt) 2018-03-27
TWI638817B (zh) 2018-10-21
CA2975372C (en) 2020-01-14
AU2016213030A1 (en) 2017-06-22
BR112017016278B1 (pt) 2022-05-10
JP6093485B2 (ja) 2017-03-08
RU2017127126A3 (pt) 2019-03-01
WO2016121953A1 (ja) 2016-08-04
TW201632526A (zh) 2016-09-16
PL3120852T3 (pl) 2019-09-30
CN107206001A (zh) 2017-09-26
RU2705154C2 (ru) 2019-11-05
CN113768935A (zh) 2021-12-10
JPWO2016121953A1 (ja) 2017-04-27

Similar Documents

Publication Publication Date Title
SG11201801024XA (en) Therapeutic or preventive compositions for il-8-related diseases
IL250990A0 (en) Materials for human care
PL3120852T3 (pl) Środek zapobiegawczy i/lub terapeutyczny przeciwko chorobom immunologicznym
GB201503139D0 (en) Diagnostic and therapeutic target
GB201519644D0 (en) Therapy and pharmaceutical composition
IL259383A (en) A compound for use in the prevention and treatment of neurodegenerative diseases
IL257689A (en) Pharmacological preparations and methods for the treatment of diseases associated with hypoxia
GB201500555D0 (en) Method and device for the treatment of diseases
GB201521260D0 (en) Therapeutic and diagnostic target
GB201521259D0 (en) Therapeutic and diagnostic target
GB201521264D0 (en) Therapeutic and diagnostic target
GB201521262D0 (en) Therapeutic and diagnostic target
GB201518306D0 (en) Therapeutic and diagnostic target
GB201518309D0 (en) Therapeutic and diagnostic target
GB201518310D0 (en) Therapeutic and diagnostic target
GB201518307D0 (en) Therapeutic and diagnostic target
GB201518188D0 (en) Therapeutic and diagnostic target
GB201518187D0 (en) Therapeutic and diagnostic target
GB201513119D0 (en) Therapeutic and diagnostic target
GB201513070D0 (en) Therapeutic and diagnostic target
GB201513114D0 (en) Therapeutic and diagnostic target
GB201513004D0 (en) Therapeutic and diagnostic target
GB201504868D0 (en) Therapeutic and diagnostic target
GB201504867D0 (en) Therapeutic and diagnostic target
GB201504863D0 (en) Therapeutic and diagnostic target